For: | Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol 2008; 14(29): 4616-4626 [PMID: 18698675 DOI: 10.3748/wjg.14.4616] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i29/4616.htm |
Number | Citing Articles |
1 |
Maria Gazouli, Maria G. Roubelakis, George E. Theodoropoulos. Stem Cells as Potential Targeted Therapy for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(5): 952 doi: 10.1097/01.MIB.0000442922.85569.21
|
2 |
Murali Krishna Mamidi, Rajarshi Pal, Vijayendran Govindasamy, Zubaidah Zakaria, Ramesh Bhonde. Treat the graft to improve the regenerative ability of the host. Medical Hypotheses 2011; 76(4): 599 doi: 10.1016/j.mehy.2011.01.010
|
3 |
Robert W. Lindblad, Laarni Ibenana, John E. Wagner, David H. McKenna, Derek J. Hei, Peiman Hematti, Larry A. Couture, Leslie E. Silberstein, Myriam Armant, Cliona M. Rooney, Adrian P. Gee, Lisbeth A. Welniak, Traci Heath Mondoro, Deborah A. Wood, David Styers. Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. Transfusion 2015; 55(3): 674 doi: 10.1111/trf.12881
|
4 |
Lei Ye, Xiaowei Wu, Na Yu, Jingxin Pan, Lianming Liao, Fangyu Wang. Clinical efficacy and safety of stem cells in refractory Crohn's disease: A systematic review. Journal of Cellular Immunotherapy 2016; 2(1): 21 doi: 10.1016/j.jocit.2016.01.001
|
5 |
Hmadcha Abdelkrim, Domínguez‐Bendala Juan, Wakeman Jane, Arredouani Mohamed, Soria Bernat. The immune boundaries for stem cell based therapies: problems and prospective solutions. Journal of Cellular and Molecular Medicine 2009; 13(8a): 1464 doi: 10.1111/j.1582-4934.2009.00837.x
|
6 |
David H. Mckenna, Sheryl Adams, Darin Sumstad, Therese Sumstad, Diane Kadidlo, Adrian P. Gee, April Durett, Debe Griffin, Albert Donnenberg, David Amrani, Deborah Livingston, Robert Lindblad, Deborah Wood, David Styers. CD34+ cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine. Cytotherapy 2010; 12(2): 170 doi: 10.3109/14653240903476446
|
7 |
Indrani Datta, Ramesh Bhonde. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?. Cell Biology International 2012; 36(7): 617 doi: 10.1042/CBI20110602
|
8 |
Christos Zavos. Digestive System Diseases. Stem Cell Biology and Regenerative Medicine 2019; : 137 doi: 10.1007/978-3-030-11965-2_8
|
9 |
HIROMI YASUDA, KOJI TANAKA, YOSHIKI OKITA, TOSHIMITSU ARAKI, SUSUMU SAIGUSA, YUJI TOIYAMA, TAKESHI YOKOE, SHIGEYUKI YOSHIYAMA, AYA KAWAMOTO, YASUHIRO INOUE, CHIKAO MIKI, MASATO KUSUNOKI. CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer. Oncology Letters 2011; 2(6): 1065 doi: 10.3892/ol.2011.415
|
10 |
Runqin Yang, Xiaoshan Yang, Shiyu Liu, Leiguo Ming, Zhifei Zhou, Yuanyuan Liang, Yu Zhao, Fuxing Zhou, Zhihong Deng, Yan Jin. Activation of the Wnt/β-Catenin Pathway by an Inflammatory Microenvironment Affects the Myogenic Differentiation Capacity of Human Laryngeal Mucosa Mesenchymal Stromal Cells. Stem Cells and Development 2018; 27(11): 771 doi: 10.1089/scd.2017.0200
|
11 |
Karolina Turnovcova, Katerina Ruzickova, Vaclav Vanecek, Eva Sykova, Pavla Jendelova. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 2009; 11(7): 874 doi: 10.3109/14653240903188947
|
12 |
Marco Pappalardo, Luigi Montesano, Francesca Toia, Antonio Russo, Sara Di Lorenzo, Francesco Dieli, Francesco Moschella, Angelo A. Leto Barone, Serena Meraviglia, Anna Barbara Di Stefano. Immunomodulation in Vascularized Composite Allotransplantation. Annals of Plastic Surgery 2019; 82(2): 245 doi: 10.1097/SAP.0000000000001763
|
13 |
Rebecca L. White, Gerard Nash, Dean P. J. Kavanagh, Caroline O. S. Savage, Neena Kalia, David Long. Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney. PLoS ONE 2013; 8(6): e66489 doi: 10.1371/journal.pone.0066489
|
14 |
Bo Li, David J Baylink, Michael H Walter, Kin-Hing William Lau, Xianmei Meng, Jun Wang, Andriy Cherkas, Xiaolei Tang, Xuezhong Qin. Targeted 25-hydroxyvitamin D3 1α-hydroxylase Adoptive Gene Therapy Ameliorates DSS-induced Colitis Without Causing Hypercalcemia in Mice. Molecular Therapy 2015; 23(2): 339 doi: 10.1038/mt.2014.201
|
15 |
Yur-Ren Kuo, Chien-Chang Chen, Shigeru Goto, Pao-Yuan Lin, Fu-Chan Wei, Chao-Long Chen. Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/854846
|
16 |
Yi Xu, David J. Baylink, Huynh Cao, Jeffrey Xiao, Maisa I. Abdalla, Samiksha Wasnik, Xiaolei Tang. Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells. International Journal of Molecular Sciences 2021; 22(17): 9516 doi: 10.3390/ijms22179516
|
17 |
Ornella Parolini, Francesco Alviano, Irene Bergwerf, Diana Boraschi, Cosimo De Bari, Peter De Waele, Massimo Dominici, Marco Evangelista, Werner Falk, Simone Hennerbichler, David C. Hess, Giacomo Lanzoni, Bing Liu, Fabio Marongiu, Colin McGuckin, Stefan Mohr, Maria Luisa Nolli, Racheli Ofir, Peter Ponsaerts, Luca Romagnoli, Abraham Solomon, Maddalena Soncini, Stephen Strom, Daniel Surbek, Sankar Venkatachalam, Susanne Wolbank, Steffen Zeisberger, Andy Zeitlin, Andreas Zisch, Cesar V. Borlongan. Toward Cell Therapy Using Placenta-Derived Cells: Disease Mechanisms, Cell Biology, Preclinical Studies, and Regulatory Aspects at the Round Table. Stem Cells and Development 2010; 19(2): 143 doi: 10.1089/scd.2009.0404
|
18 |
Francesca Toia, Elena Lo Presti, Anna Barbara Di Stefano, Marta Di Simone, Marco Trapani, Anna Maria Corsale, Carmela Picone, Francesco Moschella, Francesco Dieli, Adriana Cordova, Serena Meraviglia. An analysis of the immunomodulatory properties of human spheroids from adipose-derived stem cells. Life Sciences 2023; 321: 121610 doi: 10.1016/j.lfs.2023.121610
|
19 |
Maria Ester Bernardo, Maria Antonia Avanzini, Rachele Ciccocioppo, Cesare Perotti, Angela Maria Cometa, Antonia Moretta, Massimo Marconi, Monica Valli, Francesca Novara, Federico Bonetti, Orsetta Zuffardi, Rita Maccario, Gino Roberto Corazza, Franco Locatelli. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy 2009; 11(7): 825 doi: 10.3109/14653240903121260
|
20 |
Monica D. Prakash, Sarah Miller, Sarron Randall-Demllo, Kulmira Nurgali. Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer. Inflammatory Bowel Diseases 2016; 22(11): 2694 doi: 10.1097/MIB.0000000000000900
|
21 |
Daniel Grove, Daniel J Weiss, Viranuj Sueblinvong. Mesenchymal stem cells: promise for chronic obstructive pulmonary disease therapy?. Therapy 2009; 6(6): 779 doi: 10.2217/thy.09.66
|
22 |
Alberto Tommasini, Angela Pirrone, Gabriella Palla, Andrea Taddio, Stefano Martelossi, Sergio Crovella, Alessandro Ventura. The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?. Scandinavian Journal of Gastroenterology 2010; 45(10): 1141 doi: 10.3109/00365521.2010.492529
|
23 |
Roberta Rizzo, Giacomo Lanzoni, Marina Stignani, Diana Campioni, Francesco Alviano, Francesca Ricci, Pier Luigi Tazzari, Loredana Melchiorri, Sergio Zaccaria Scalinci, Antonio Cuneo, Laura Bonsi, Francesco Lanza, Gian Paolo Bagnara, Olavio R. Baricordi. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. Cytotherapy 2011; 13(5): 523 doi: 10.3109/14653249.2010.542460
|
24 |
Ainsley M. Robinson, Samy Sakkal, Anthony Park, Valentina Jovanovska, Natalie Payne, Simona E. Carbone, Sarah Miller, Joel C. Bornstein, Claude Bernard, Richard Boyd, Kulmira Nurgali. Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(11): G1115 doi: 10.1152/ajpgi.00174.2014
|
25 |
R. C. Mifflin, I. V. Pinchuk, J. I. Saada, D. W. Powell. Intestinal myofibroblasts: targets for stem cell therapy. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 300(5): G684 doi: 10.1152/ajpgi.00474.2010
|
26 |
Heinrich Jasper. Exploring the physiology and pathology of aging in the intestine ofDrosophila melanogaster. Invertebrate Reproduction & Development 2015; 59(sup1): 51 doi: 10.1080/07924259.2014.963713
|
27 |
Shirin Moossavi, Hongyu Zhang, Jun Sun, Nima Rezaei. Host–microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer. Expert Review of Clinical Immunology 2013; 9(5): 409 doi: 10.1586/eci.13.27
|
28 |
Giacomo Lanzoni, Francesco Alviano, Cosetta Marchionni, Laura Bonsi, Roberta Costa, Laura Foroni, Giulia Roda, Andrea Belluzzi, Alessandra Caponi, Francesca Ricci, Pier Luigi Tazzari, Pasqualepaolo Pagliaro, Roberta Rizzo, Francesco Lanza, Olavio Roberto Baricordi, Gianandrea Pasquinelli, Enrico Roda, Gian Paolo Bagnara. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. Cytotherapy 2009; 11(8): 1020 doi: 10.3109/14653240903253840
|
29 |
Derek J. Hei, David H. McKenna. Mesenchymal Stromal Cells. 2013; : 317 doi: 10.1007/978-1-4614-5711-4_16
|
30 |
Boon C. Heng, Catherine M. Cowan, Shubhayu Basu. Temperature and calcium ions affect aggregation of mesenchymal stem cells in phosphate buffered saline. Cytotechnology 2008; 58(2): 69 doi: 10.1007/s10616-008-9174-8
|
31 |
Noor Jawad, Natalie Direkze, Simon J. Leedham. Inflammation and Gastrointestinal Cancers. Recent Results in Cancer Research 2011; 185: 99 doi: 10.1007/978-3-642-03503-6_6
|
32 |
Natalie E. Duran, Daniel W. Hommes. Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therapeutic Advances in Gastroenterology 2016; 9(4): 533 doi: 10.1177/1756283X16642190
|
33 |
Young-Il Yoon, Jae-Sam Hwang, Tae-Won Goo, Myung-Sae Han, Mi-Young Ahn, Eun-Young Yun. Primary Cultures of Drosophila melanogaster Gut Cells for Studies of Intestinal Stem Cell Regulation. Journal of Life Science 2012; 22(5): 621 doi: 10.5352/JLS.2012.22.5.621
|
34 |
Adam F. Prasanphanich, Christopher T. Johnson, Andrey Krasnopeyev, Shraddha Cantara, Cristin Roach, Sanjeev Gumber, Raghavan Chinnadurai, Jacques Galipeau, Luke Brewster, J. David Prologo. Image-Guided Transarterial Directed Delivery of Human Mesenchymal Stem Cells for Targeted Gastrointestinal Therapies in a Swine Model. Journal of Vascular and Interventional Radiology 2019; 30(7): 1128 doi: 10.1016/j.jvir.2018.09.034
|
35 |
Lei Ye, Lei X. Sun, Min H. Wu, Jin Wang, Xin Ding, Hui Shi, Sheng L. Lu, Lin Wu, Juan Wei, Liang Li, Yu F. Wang. A Simple System for Differentiation of Functional Intestinal Stem Cell-like Cells from Bone Marrow Mesenchymal Stem Cells. Molecular Therapy - Nucleic Acids 2018; 13: 110 doi: 10.1016/j.omtn.2018.08.017
|
36 |
Fabiola Gutierrez-Orozco, Jennifer M. Thomas-Ahner, Lisa D. Berman-Booty, Jeffrey D. Galley, Chureeporn Chitchumroonchokchai, Thomas Mace, Sunit Suksamrarn, Michael T. Bailey, Steven K. Clinton, Gregory B. Lesinski, Mark L. Failla. Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice. Molecular Nutrition & Food Research 2014; 58(6): 1226 doi: 10.1002/mnfr.201300771
|
37 |
Lloyd Mayer, William M. Pandak, Gil Y. Melmed, Stephen B. Hanauer, Kristine Johnson, Denise Payne, Herbert Faleck, Robert J. Hariri, Steven A. Fischkoff. Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease. Inflammatory Bowel Diseases 2013; 19(4): 754 doi: 10.1097/MIB.0b013e31827f27df
|
38 |
Li Cui, Liang Feng, Zhen Hai Zhang, Xiao Bin Jia. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. International Immunopharmacology 2014; 23(1): 294 doi: 10.1016/j.intimp.2014.09.005
|
39 |
Karen Bieback, Marianna Karagianni, Gerlinde Schmidtke-Schrezenmeier, Natalie Fekete, Hubert Schrezenmeier. Stem Cell-Based Tissue Repair. 2010; : 178 doi: 10.1039/9781849732246-00178
|
40 |
Jacobo Trebol Lopez, Tihomir Georgiev Hristov, Mariano García-Arranz, Damián García-Olmo. Stem Cell Therapy for Digestive Tract Diseases: Current State and Future Perspectives. Stem Cells and Development 2011; 20(7): 1113 doi: 10.1089/scd.2010.0277
|
41 |
Evan Colletti, Deena El Shabrawy, Melisa Soland, Takashi Yamagami, Saloomeh Mokhtari, Craig Osborne, Karen Schlauch, Esmail D. Zanjani, Christopher D. Porada, Graça Almeida‐Porada. EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool. The FASEB Journal 2013; 27(6): 2111 doi: 10.1096/fj.12-205054
|
42 |
Jacobo Trebol Lopez, Tihomir Georgiev-Hristov, Mariano García-Arranz, Damián García-Olmo. Regenerative Medicine and Cell Therapy. 2013; : 245 doi: 10.1007/978-1-62703-098-4_12
|
43 |
Lijun Wang, Douglas C. Moore, Jiahui Huang, Yuhong Wang, Hu Zhao, Jerry D‐H Yue, Cynthia L. Jackson, Peter J. Quesenberry, Weibiao Cao, Wentian Yang.
SHP2 regulates the development of intestinal epithelium by modifying OSTERIX
+
crypt stem cell self‐renewal and proliferation
. The FASEB Journal 2021; 35(1) doi: 10.1096/fj.202001091R
|
44 |
Mohamed A.H. Ahmed, Darryl Jackson, Rashmi Seth, Adrian Robins, Dileep N. Lobo, Ian P.M. Tomlinson, Mohammad Ilyas. CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation. Inflammatory Bowel Diseases 2010; 16(5): 795 doi: 10.1002/ibd.21134
|
45 |
Adrian Yemm, David Adams, Neena Kalia. Targeting the delivery of systemically administered haematopoietic stem/progenitor cells to the inflamed colon using hydrogen peroxide and platelet microparticle pre-treatment strategies. Stem Cell Research 2015; 15(3): 569 doi: 10.1016/j.scr.2015.10.001
|
46 |
Joanne Cooper, Iszara Blake, James O Lindsay, Christopher J Hawkey. Living with Crohn’s disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study). BMJ Open 2017; 7(9): e015201 doi: 10.1136/bmjopen-2016-015201
|
47 |
Lu Liang, Chunlan Dong, Xiaojun Chen, Zhihong Fang, Jie Xu, Meng Liu, Xiaoguang Zhang, Dong Sheng Gu, Ding Wang, Weiting Du, Delin Zhu, Zhong Chao Han. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Mice Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis. Cell Transplantation 2011; 20(9): 1395 doi: 10.3727/096368910X557245
|
48 |
Shuai Liang, Xin Deng, Lei Lei, Yao Zheng, Jiao Ai, Linlin Chen, Hui Xiong, Zhinan Mei, Yung-Chi Cheng, Yongshen Ren. The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01466
|
49 |
Cheng-Liang Zhang, Si Zhang, Wen-Xi He, Jing-Li Lu, Yan-Jiao Xu, Jin-Yu Yang, Dong Liu. Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression. Life Sciences 2017; 186: 125 doi: 10.1016/j.lfs.2017.08.010
|
50 |
Jason P. Glotzbach, Victor W. Wong, Geoffrey C. Gurtner, Michael T. Longaker. Regenerative Medicine. Current Problems in Surgery 2011; 48(3): 148 doi: 10.1067/j.cpsurg.2010.11.002
|
51 |
Graça Almeida-Porada, Melisa Soland, Joana Boura, Christopher D Porada. Regenerative Medicine: Prospects for the Treatment of Inflammatory Bowel Disease. Regenerative Medicine 2013; 8(5): 631 doi: 10.2217/rme.13.52
|